BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 8690291)

  • 1. Expression and mutation of H-ras in uterine cervical cancer.
    Lee JH; Lee SK; Yang MH; Ahmed MM; Mohiuddin M; Lee EY
    Gynecol Oncol; 1996 Jul; 62(1):49-54. PubMed ID: 8690291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Low-risk" and "high-risk" HPV-infection and K-ras gene point mutations in human cervical cancer: a study of 31 cases.
    Stenzel A; Semczuk A; Rózyńskal K; Jakowicki J; Wojcierowski J
    Pathol Res Pract; 2001; 197(9):597-603. PubMed ID: 11569923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of ras point mutations and human papillomavirus 16 and 18 in cervical carcinomata and their metastases.
    Willis G; Jennings B; Ball RY; New NE; Gibson I
    Gynecol Oncol; 1993 Jun; 49(3):359-64. PubMed ID: 8390962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of H, K, and N-ras point mutations in stage IB cervical carcinoma.
    Grendys EC; Barnes WA; Weitzel J; Sparkowski J; Schlegel R
    Gynecol Oncol; 1997 May; 65(2):343-7. PubMed ID: 9159349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detection of K-ras oncogene activation in human lung cancer and its possible clinical application].
    Zhang G; Sun Y; Wang M
    Zhonghua Jie He He Hu Xi Za Zhi; 1995 Oct; 18(5):282-4, 317. PubMed ID: 8762479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relevance of Ki-67 antigen expression and K-ras mutation in colorectal liver metastases.
    Petrowsky H; Sturm I; Graubitz O; Kooby DA; Staib-Sebler E; Gog C; Köhne CH; Hillebrand T; Daniel PT; Fong Y; Lorenz M
    Eur J Surg Oncol; 2001 Feb; 27(1):80-7. PubMed ID: 11237496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of RAS family genes in urothelial carcinoma.
    Boulalas I; Zaravinos A; Karyotis I; Delakas D; Spandidos DA
    J Urol; 2009 May; 181(5):2312-9. PubMed ID: 19303097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.
    Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H
    Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of adenocarcinoma of the cervix.
    Parker MF; Arroyo GF; Geradts J; Sabichi AL; Park RC; Taylor RR; Birrer MJ
    Gynecol Oncol; 1997 Feb; 64(2):242-51. PubMed ID: 9038270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression status and mutational analysis of the ras and B-raf genes in ovarian granulosa cell and epithelial tumors.
    Jamieson S; Alexiadis M; Fuller PJ
    Gynecol Oncol; 2004 Dec; 95(3):603-9. PubMed ID: 15581971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular genetics of malignant insulinoma.
    Pavelic K; Hrascan R; Kapitanovic S; Vranes Z; Cabrijan T; Spaventi S; Korsic M; Krizanac S; Li YQ; Stambrook P; Gluckman JL; Pavelic ZP
    Anticancer Res; 1996; 16(4A):1707-17. PubMed ID: 8712689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ki-ras codon 12 point and P53 mutations: a molecular examination of the main tumor, liver, portal vein, peripheral arterial blood and para-aortic lymph node in pancreatic cancer.
    Yamaguchi K; Chijiiwa K; Torato N; Kinoshita M; Tanaka M
    Am J Gastroenterol; 2000 Aug; 95(8):1939-45. PubMed ID: 10950039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of the ras genes in female genital tract cancer.
    Mammas IN; Zafiropoulos A; Spandidos DA
    Int J Oncol; 2005 May; 26(5):1241-55. PubMed ID: 15809715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of O6-methylguanine-DNA methyltransferase in soft tissue sarcomas: association with K-ras mutations.
    Kim JI; Suh JT; Choi KU; Kang HJ; Shin DH; Lee IS; Moon TY; Kim WT
    Hum Pathol; 2009 Jul; 40(7):934-41. PubMed ID: 19356788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. H-ras codon 12 mutation in cervical dysplasia.
    Van Le L; Stoerker J; Rinehart CA; Fowler WC
    Gynecol Oncol; 1993 May; 49(2):181-4. PubMed ID: 8389312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 and p21/Waf1 protein expression and K-ras codon 12 mutation in carcinoma of the papilla of Vater.
    Zhao B; Kimura W; Futakawa N; Muto T; Kubota K; Harihara Y; Takayama T; Makuuchi M
    Am J Gastroenterol; 1999 Aug; 94(8):2128-34. PubMed ID: 10445539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. H-ras mutation is an additional event of sarcomatous transformation in aerodigestive spindle cell carcinoma.
    Shiratsuchi H; Hirakawa N; Saito T; Oda Y; Yamamoto H; Tomita K; Yamamoto T; Tsuneyoshi M
    Oncol Rep; 2004 Mar; 11(3):597-604. PubMed ID: 14767509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular staging of non-small cell lung cancer according to K-ras genotypes.
    Rosell R; Monzó M; Pifarré A; Ariza A; Sánchez JJ; Moreno I; Maurel J; López MP; Abad A; de Anta JM
    Clin Cancer Res; 1996 Jun; 2(6):1083-6. PubMed ID: 9816271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular oncological study on DNA ploidy, Ki-ras point mutation, and p21 expression in colorectal cancer].
    Yamazaki K; Sato K; Hirata S; Ikeda K; Kubo Y; Matsui H; Ogawa K
    Nihon Geka Gakkai Zasshi; 1994 Apr; 95(4):242-7. PubMed ID: 8196591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low mutational rate of K-ras codon 12 in singular bronchoscopy specimens in suspected lung cancer.
    Spasova I; Novotna H; Vachtenheim J; Bartosova H; Patek J; Hoserova V; Zatloukal P; Kinkor Z
    Neoplasma; 2005; 52(3):255-9. PubMed ID: 15875089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.